Usage and safety of fingolimod in multiple sclerosis

被引：0
|
作者：
Nieves Sedano, M. [1 ]
Caro Teller, J. M. [1 ]
Fernandez Redondo, D. [1 ]
Garcia Munoz, C. [1 ]
Lazaro Cebas, A. [1 ]
Pablos Bravo, S. [1 ]
Alioto, D. [1 ]
Gomez Valbuena, I. [1 ]
Ferrari Piquero, J. M. [1 ]
机构：
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2016年 / 38卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT053
引用
收藏
页码：588 / 589
页数：2
相关论文
共 50 条
  • [1] Fingolimod safety in patients with multiple sclerosis
    Carrascosa Piquer, Olga
    Antonino de la Camara, Gonzalo
    Aparicio, Celia
    de la Vega, Ivan
    Mejia, Luisa
    Garcia del Busto, Natalia
    Quintana, Belen
    Sanchez, Agustin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 219 - 219
  • [2] Efficacy and Safety of Fingolimod for Multiple Sclerosis in Singapore
    Quek, A. M. L.
    Soon, D.
    Ong, B. K. C.
    Pang, X. J.
    Tye, J. S. N.
    Tan, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 395 - 395
  • [3] Fingolimod for Multiple Sclerosis; Mechanism of Action, Safety and Toxicity
    Tolou-Ghamari, Zahra
    Mazdak, Hamid
    ARCHIVES OF NEUROSCIENCE, 2016, 3 (03)
  • [4] Fingolimod for Multiple Sclerosis
    Pelletier, Daniel
    Hafler, David A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04): : 339 - 347
  • [5] Safety and Efficacy of Fingolimod and Ocrelizumab in Pediatric Patients With Multiple Sclerosis
    Spirek, Benton
    Brenton, J. Nicholas
    PEDIATRIC NEUROLOGY, 2025, 164 : 89 - 96
  • [6] Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings
    Kappos, Ludwig
    Cohen, Jeffrey
    Collins, William
    de Vera, Ana
    Zhang-Auberson, Lixin
    Ritter, Shannon
    von Rosenstiel, Philipp
    Francis, Gordon
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (04) : 494 - 504
  • [7] Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis
    Ward, Melanie D.
    Jones, David E.
    Goldman, Myla D.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (07) : 989 - 998
  • [8] Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis
    Swallow, Elyse
    Patterson-Lomba, Oscar
    Yin, Lei
    Mehta, Rina
    Pelletier, Corey
    Kao, David
    Sheffield, James K.
    Stonehouse, Tim
    Signorovitch, James
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (04) : 275 - 286
  • [9] Fingolimod in Relapsing Remitting Multiple Sclerosis: Short Term Safety Profile
    Altunrende, Burcu
    Shugaiv, Erkingul
    Yabalak, Ahmet
    Topcular, Baris
    Kocaslan, Meryem
    Pabuscu, Elvan
    Kurtuncu, Murat
    Demir, Gulsen Akman
    Eraksoy, Mefkure
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 928 - 928
  • [10] Safety and Efficacy of Fingolimod in Treatment-Naive Multiple Sclerosis Patients
    Marriott, James J.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 43 - 50
12345